Davidson Trust Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$607K Sell
525
-2
-0.4% -$2.36K 0.24% 101
2026
Q2
$632K Buy
527
+54
+11% +$55.2K 0.25% 103
2026
Q1
$435K Sell
473
-72
-13% -$73K 0.19% 119
2025
Q4
$586K Sell
545
-99
-15% -$94.7K 0.24% 98
2025
Q3
$491K Hold
644
– – 0.2% 102
2025
Q2
$502K Sell
644
-211
-25% -$164K 0.23% 99
2025
Q1
$706K Buy
855
+320
+60% +$266K 0.34% 73
2024
Q4
$413K Sell
535
-3
-0.6% -$2.48K 0.21% 101
2024
Q3
$477K Buy
+538
New +$484K 0.24% 97

Other funds holding LLY

Davidson Trust Company's LLY Position: Q3 2026 in Review

Davidson Trust Company reduced its Eli Lilly (LLY) stake by 0.38% in Q3 2026, selling an estimated $2.36K and leaving 525 shares worth $607K. The position accounts for 0.24% of the portfolio, ranked #101.

Davidson Trust Company first reported a position in LLY in Q3 2024 and has held it in 9 quarters since. The position peaked at $706K in Q1 2025. 4,212 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Davidson Trust Company held 525 shares of Eli Lilly worth $607K as of Q3 2026.
  • Davidson Trust Company sold 2 Eli Lilly shares in Q3 2026, an estimated $2.36K.
  • Eli Lilly made up 0.24% of Davidson Trust Company's portfolio in Q3 2026, its #101 holding.
  • Davidson Trust Company first reported a position in Eli Lilly in Q3 2024 and has held it in 9 quarters since.
  • Davidson Trust Company's Eli Lilly position peaked at $706K in Q1 2025.
  • 4,212 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Davidson Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.